AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Market Watch: Nutex Health's Earnings Report and Industry Comparison
ByAinvest
Thursday, Aug 14, 2025 4:45 pm ET1min read
Nutex Health will release its quarterly earnings report on Thursday, August 14. Analysts expect an EPS of $-5.43. The market awaits the announcement, hoping for news of surpassing estimates and providing upbeat guidance for the next quarter. Shares of Nutex Health are trading at $96.12, up 693.26% over the last 52-week period. The consensus rating for Nutex Health is Buy, with an average one-year price target of $262.5, indicating a potential 173.1% upside.
Nutex Health Inc. (NUTX), a physician-led healthcare services and operations company based in Houston, Texas, is set to release its quarterly earnings report on Thursday, August 14. Analysts anticipate an earnings per share (EPS) of $-1.58, marking a potential rise in revenue and a continuation of the company's growth trajectory [1].The Houston-based company operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. Nutex Health's PHM segment establishes and operates independent physician associations, offering a cloud-based platform for healthcare organizations to provide value-based care and population health management. The Real Estate segment owns and leases land and hospital buildings, while the Hospital segment develops and operates a network of micro-hospitals, specialty hospitals, and hospital outpatient departments [2].
Shares of Nutex Health are currently trading at $96.12, reflecting a significant increase of 693.26% over the last 52-week period. The consensus rating for Nutex Health remains "Buy," with an average one-year price target of $262.5, suggesting a potential 173.1% upside [2].
Analysts expect Nutex Health to report a 132.0% increase in revenue to $176.475 million for the period ending June 30, 2025, compared to $76.08 million a year ago [1]. The market awaits the announcement with anticipation, hoping for news of surpassing estimates and providing upbeat guidance for the next quarter.
In addition to the expected earnings, investors will also be watching for updates on the company's operational performance, strategic initiatives, and future growth prospects. Nutex Health's strong market performance and positive analyst ratings indicate investor confidence in the company's ability to continue delivering value to shareholders.
References:
[1] https://www.tradingview.com/news/reuters.com,2025:newsml_L8N3U41SO:0-nutex-health-inc-expected-to-post-a-loss-of-1-58-a-share-earnings-preview/
[2] https://www.marketbeat.com/stocks/NASDAQ/NUTX/
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet